Research on post-marketing drug risk management measures of FDA and its implication for China:a case of thalidomide
CHEN Jin-min
LIU Peng-cheng
YU Zheng
Machine-generated Keywords：
Publication Date：2020-12-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 2654-2659 )